SCHEMBL9318166

SCHEMBL9318166

CC(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(C(=O)O)=CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 8/20 0.74
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
MAPK1 P28482 3/20 0.50
CYP2C9 P11712 2/20 0.50
TSHR P16473 2/20 0.50
HIF1A Q16665 2/20 0.50
ABCB11 O95342 2/20 0.50
SHBG P04278 2/20 0.50
SERPINA6 P08185 2/20 0.50
CYP2C19 P33261 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
SLC22A2 O15244 1/20 0.50
SLC22A1 O15245 1/20 0.50
NR1I2 O75469 1/20 0.50
SLC22A3 O75751 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8162541 0.87 SRD5A2 (0.70) SRD5A2SRD5A1
SCHEMBL8162542 0.87 SRD5A2 (0.70) SRD5A2SRD5A1
SCHEMBL8150323 0.85 SRD5A2 (1.00) SRD5A2SRD5A1
SCHEMBL8150325 0.85 SRD5A2 (1.00) SRD5A2SRD5A1
SCHEMBL9402948 0.76 CYP3A4 (0.68) CYP3A4ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL9402957 0.76 CYP3A4 (0.68) CYP3A4ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL9318780 0.74 SRD5A2 (0.73) SRD5A2MEN1KMT2AGPBAR1SRD5A1
SCHEMBL9578020 0.74 LMNA (0.69) SRD5A2CYP3A4ALDH1A1SMN1; SMN2LMNA
SCHEMBL9822464 0.74 SRD5A2 (0.55) SRD5A2SRD5A1
SCHEMBL9822632 0.72 SRD5A2 (0.76) SRD5A2SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0576603-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO. INC. (US) 1994-01-05 EP disclosed